Nuclear pharmacy is a unique branch of pharmacy services that focuses on the proper, safe management and use of radiopharmaceuticals. Most of pharmacist spent their time in traditional services while few renders clinical services in hospital setting even recruitment and regulatory body also demand undergraduate qualification which may find insufficient to render services. It is a matter of question how many provides clinical or pharmaceutical care? But spending a time in clinical activities by pharmacist is an issue of debate. After satisfactory completion of project in this area, attempt has been made by this article to explore our perception on scope, education and functions of pharmacist especially by hospital and by clinical pharmacist. How pharmacist can perform pharmaceutical care in this unique service area is discussed and responsibilities of pharmacist in nuclear pharmacist are proposed.

Background: Radiopharmaceutical plays a critical role in modern medicine primarily for the diagnostic purpose, but also for monitoring disease progression and response to treatment. Identification, resolution and prevention of medication related problems is a vital role of healthcare professionals Drug related problems are an important challenge that may affect morbidity and mortality, as well as the patient's quality of life. The Drug Related Problems recorded by the pharmacists were found to be of clinical significance lends support to actively including clinical pharmacists in the therapeutic health care team. Method: Data was collected in data collection form using patient's medication file. Patients visiting department of nuclear medicine Gujarat Cancer and Research Institute, Ahmedabad were recruited in study. Data was collected in data collection form By reviewing patient's medication file. Result: Total 65 patient included in the study and 146 DRPs identified in 56 (15.47%) patients. The frequency of Drug Related Problem was 2.60 per patient. Most common problems came to know were logistic problem(35.38%), repetition of report (35.38%), Imagine problem (37.69%), patient identifying problem (27.69%), dose selection problem (24.62%), administration problem (87.69%) and vein identifying problem (12.31%). Conclusion: It is concluded that apart from general medicines, Drug Related Problems also presented in nuclear and Radio Pharmaceutical product. Moreover there is a need to develop specific classification system to identify the Drug Related Problems associated with radio and nuclear pharmacy.